2,2'-((Cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile

Catalog No. :
ACIVDI361
CAS No. :
219538-01-9
Molecular Formula :
C23H16N4S2
Molecular Weight :
412.54

IUPAC Name:2,2'-((cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile

2,2'-((Cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-((Cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile
IUPAC Name2,2'-((cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile
Molecular FormulaC23H16N4S2
Molecular Weight412.54
SMILESN#C/C(C#N)=C/C1=CC(C2=C(CCC2)C3=C(C)SC(/C=C(C#N)/C#N)=C3)=C(C)S1
InChI KeyDHFZRDNXGKWMOY-UHFFFAOYSA-N
SynonymPropanedinitrile, 2,2′-[1-cyclopentene-1,2-diylbis[(5-methyl-4,2-thiophenediyl)methylidyne]]bis-;2,2'-((cyclopent-1-ene-1,2-diylbis(5-methylthiophene-4,2-diyl))bis(methaneylylidene))dimalononitrile;2,2 '- (cyclopent-1-ene-1,2-diylbis (5-methylthiophene-4,2-diyl)) bis (methylylidene)) dimerlonitrile
CAS No.219538-01-9

Synthetic Route by SureRoute

1. ACIVDI361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVDI361 route product structure diagram
    ACIVDI361219538-01-9
Inquiry

2. ACIVDI361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIVDI361 route product structure diagram
    ACIVDI361219538-01-9
Inquiry

Comments (0)